NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
11.13
+0.48 (4.51%)
At close: Oct 8, 2025, 4:00 PM EDT
11.18
+0.05 (0.44%)
After-hours: Oct 8, 2025, 4:37 PM EDT
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $368.20 million as of October 8, 2025. Its market cap has increased by 69.05% in one year.
Market Cap
368.20M
Enterprise Value
377.58M
1-Year Change
69.05%
Ranking
Category
Stock Price
$11.13
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has decreased from $393.28M to $368.20M, a decrease of -6.38%. That is a compound annual growth rate of -1.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 352.32M | 5.48% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | 393.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |